Literature DB >> 8558846

Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.

R K Vartanian1, N Weidner.   

Abstract

BACKGROUND: Tumor angiogenesis is necessary for tumor growth and metastasis, and increasing intratumoral microvessel density (MVD) in prostate carcinoma has been shown in several studies to be associated with increasing tumor stage. But, the relationships of endothelial cell proliferation to intratumoral MVD, tumor cell proliferation, and Gleason's score remain unknown in prostate carcinoma. EXPERIMENTAL
DESIGN: Using a double-immunolabeling technique (paraffin-reactive MIB1 Ab to determine Ki67 labeling index (Ki67LI) and anti-CD34 to quantify microvessels), we immunostained 20 prostatic carcinomas and adjacent benign prostate hyperplasia (BH) and four cases of trauma-induced granulation tissue. We correlated intratumoral endothelial cell proliferation with intratumoral MVD, tumor cell proliferation, and Gleason's score, and we compared these measurements with endothelial cell proliferation, MVD, and epithelial cell proliferation in adjacent BH.
RESULTS: The intratumoral endothelial cell proliferation index (mean 0.15%) and intratumoral MVD measured 30-fold (p = 0.00007) and 1.9-fold (p = 0.000003) greater than that of adjacent BH, respectively. However, the intratumoral endothelial cell proliferation index did not correlate with intratumoral MVD, tumor cell proliferation, or Gleason's score. Nor did intratumoral MVD correlate with tumor cell proliferation. In comparison, the mean MVD and endothelial cell proliferation rates in granulation tissue were 199 and 6.50%, respectively, the latter 43-fold greater than the mean intratumoral endothelial cell proliferation index (p = 0.00023).
CONCLUSIONS: Endothelial cells are actively proliferating in prostatic carcinoma, and their proliferation appears independent of intratumoral MVD and tumor cell proliferation. Yet, the relatively low intratumoral hyperplasia, suggests that endothelial cell migration and capillary remodeling play an important role in neovascularization of prostatic carcinoma, especially when compared with granulation tissue, which showed a 43-fold greater endothelial cell proliferation index. Moreover, the lack of correlation of intratumoral endothelial cell proliferation and intratumoral MVD with tumor cell proliferation suggests that tumor angiogenesis and tumor-cell proliferation are regulated by different mechanisms.

Entities:  

Mesh:

Year:  1995        PMID: 8558846

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  23 in total

Review 1.  Descriptive analysis and quantification of angiogenesis in human brain tumors.

Authors:  R D Folkerth
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Incidental prostatic carcinoma. A predictive role of neoangiogenesis and comparison with other prognostic factors.

Authors:  M Volavsek; A Masera; Z Ovcak
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Evaluation of angiogenesis by morphometric analysis of blood vessels in dysplastic and neoplastic lesions of canine gingiva.

Authors:  M Martano; P Maiolino; M Cataldi; B Restucci
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

4.  Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer.

Authors:  Danni Li; Hanching Chiu; Vinita Gupta; Daniel W Chan
Journal:  Clin Chim Acta       Date:  2012-06-18       Impact factor: 3.786

5.  Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma.

Authors:  Youichi Kumagai; Jun Sobajima; Morihiro Higashi; Toru Ishiguro; Minoru Fukuchi; Keiichiro Ishibashi; Erito Mochiki; Koji Yakabi; Tatsuyuki Kawano; Jun-ichi Tamaru; Hideyuki Ishida
Journal:  Int Surg       Date:  2015-04

6.  Angiogenesis and the growth potential of craniopharyngiomas.

Authors:  Sergio Vidal; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

7.  Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity.

Authors:  G Klement; S Baruchel; J Rak; S Man; K Clark; D J Hicklin; P Bohlen; R S Kerbel
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

8.  Immunohistochemical detection of retinoic acid receptor-alpha in prostate carcinoma: correlation with proliferative activity and tumor grade.

Authors:  K Gyftopoulos; P Perimenis; G Sotiropoulou-Bonikou; G Sakellaropoulos; I Varakis; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

9.  Clinical implications of EphB4 receptor expression in pancreatic cancer.

Authors:  Man Li; Zuowei Zhao
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

10.  Thymidine phosphorylase and angiogenesis in early stage esophageal squamous cell carcinoma.

Authors:  Youichi Kumagai; Tetsuhiko Tachikawa; Morihiro Higashi; Jun Sobajima; Akemi Takahashi; Kunihiko Amano; Minoru Fukuchi; Kei-Ichiro Ishibashi; Erito Mochiki; Koji Yakabi; Jun-Ichi Tamaru; Hideyuki Ishida
Journal:  Esophagus       Date:  2017-07-24       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.